Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Gaudernack · SciRah

Researcher profile · Semantic Scholar

G. Gaudernack

Share profile

G. Gaudernack — researcher profile on SciRah

h-index: 49
Works: 214
Citations: 9,128

Most-cited papers

Therapeutic vaccines for cancer: an overview of clinical trials
I. Melero, G. Gaudernack, W. Gerritsen, C. Huber +7 more
2014Nature Reviews Clinical Oncology729 citations Open access
Semantic Scholar
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
E. O. Vik-Mo, M. Nyakas, Birthe Mikkelsen, M. Moe +12 more
2013Cancer Immunology and Immunotherapy296 citations Open access
Semantic Scholar
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
P. Brunsvig, S. Aamdal, M. Gjertsen, G. Kvalheim +7 more
2006Cancer Immunology and Immunotherapy256 citations
Semantic Scholar
Long‐term follow‐up of patients with resected pancreatic cancer following vaccination against mutant K‐ras
S. Wedén, M. Klemp, I. Gladhaug, M. Møller +3 more
2011International Journal of Cancer170 citations Open access
Semantic Scholar
Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
P. Brunsvig, J. Kyte, C. Kersten, S. Sundstrøm +5 more
2011Clinical Cancer Research166 citations Open access
Semantic Scholar
Immune escape of cancer cells with beta2‐microglobulin loss over the course of metastatic melanoma
A. del Campo, J. Kyte, Javier Carretero, Svitlana Zinchencko +7 more
2014International Journal of Cancer139 citations Open access
Semantic Scholar
Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines
Ping Wang, Quanli Gao, Z. Suo, E. Munthe +6 more
2013PLoS ONE138 citations Open access
Semantic Scholar
Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients
J. Kyte, G. Gaudernack, S. Dueland, Sissel Trachsel +2 more
2011Clinical Cancer Research124 citations Open access
Semantic Scholar
Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
H. Almåsbak, E. Walseng, A. Kristian, Myhre +7 more
2015Gene Therapy107 citations
Semantic Scholar
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
L. Mu, J. Kyte, Gunnar Kvalheim, S. Aamdal +6 more
2005British Journal of Cancer107 citations Open access
Semantic Scholar
Formation of biocompatible nanocapsules with emulsion core and pegylated shell by polyelectrolyte multilayer adsorption.
K. Szczepanowicz, H. Hoel, L. Szyk-Warszyńska, E. Bielanska +4 more
2010Langmuir102 citations
Semantic Scholar
Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention
Aikaterini Nasi, S. McArdle, G. Gaudernack, G. Westman +6 more
2020Toxicology Reports100 citations Open access
Semantic Scholar
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
Else M. Inderberg Suso, S. Dueland, A. Rasmussen, T. Vetrhus +3 more
2011Cancer Immunology and Immunotherapy99 citations Open access
Semantic Scholar
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer
W. Lilleby, G. Gaudernack, P. Brunsvig, L. Vlatkovic +4 more
2017Cancer Immunology and Immunotherapy93 citations
Semantic Scholar
p21‐ras‐peptide‐specific T‐cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly → Asp)
B. Fossum, T. Gedde-Dahl, J. Breivik, J. A. Eriksen +3 more
2007International Journal of Cancer92 citations
Semantic Scholar
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
J. Kyte, G. Gaudernack
2006Cancer Immunology and Immunotherapy90 citations Open access
Semantic Scholar
A TCR-based Chimeric Antigen Receptor
E. Walseng, H. Köksal, I. M. Sektioglu, A. Fåne +5 more
2017Scientific Reports88 citations Open access
Semantic Scholar
NY‐ESO‐1 protein expression and humoral immune responses in prostate cancer
A. Fosså, A. Berner, S. Fosså, E. Hernes +2 more
2004The Prostate79 citations
Semantic Scholar
Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display
A. Fosså, L. Alsøe, R. Crameri, S. Funderud +2 more
2004Cancer Immunology and Immunotherapy72 citations Open access
Semantic Scholar
NK cells specifically TCR-dressed to kill cancer cells
N. Mensali, Pierre Dillard, Michael Hebeisen, S. Lorenz +8 more
2019EBioMedicine71 citations Open access
Semantic Scholar
T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
E. Inderberg, S. Wälchli, M. R. Myhre, Sissel Trachsel +3 more
2017Oncoimmunology68 citations Open access
Semantic Scholar
Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency.
Fang Zhao, A. Sucker, S. Horn, Christina Heeke +13 more
2016Cancer Research67 citations Open access
Semantic Scholar
Transiently redirected T cells for adoptive transfer.
H. Almåsbak, E. Rian, Hanna Julie Hoel, M. Pule +4 more
2011Cytotherapy67 citations
Semantic Scholar
A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines
S. Jarnjak-Jankovic, H. Hammerstad, S. Saebøe-Larssen, G. Kvalheim +1 more
2007BMC Cancer64 citations Open access
Semantic Scholar
T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells
J. Kyte, G. Kvalheim, K. Lislerud, P. Thor Straten +3 more
2007Cancer Immunology and Immunotherapy62 citations
Semantic Scholar
Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination
J. Kyte, G. Kvalheim, S. Aamdal, S. Saebøe-Larssen +1 more
2005Cancer Gene Therapy59 citations Open access
Semantic Scholar
Improving the efficacy of cancer immunotherapy.
John P. Copier, A. Dalgleish, Cedrik M. Britten, L. Finke +9 more
2009European Journal of Cancer54 citations
Semantic Scholar
Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
R. Hunger, Kristin Kernland Lang, Carrie Markowski, Sissel Trachsel +5 more
2011Cancer Immunology and Immunotherapy53 citations Open access
Semantic Scholar
Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination
J. Kyte, Sissel Trachsel, B. Risberg, P. Straten +2 more
2009Cancer Immunology and Immunotherapy52 citations
Semantic Scholar
Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
J. Kyte, S. Aamdal, S. Dueland, Stein Sæbøe-Larsen +5 more
2016Oncoimmunology49 citations Open access
Semantic Scholar
Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy.
A. Rasmussen, G. Borelli, Hanna Julie Hoel, K. Lislerud +3 more
2010JIM - Journal of Immunological Methods49 citations
Semantic Scholar
Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination
G. L. Hansen, G. Gaudernack, P. Brunsvig, M. Cvancarova +1 more
2015Cancer Immunology and Immunotherapy47 citations
Semantic Scholar
Identification of Cancer Stem-like Side Population Cells in Ovarian Cancer Cell Line OVCAR-3
Quanli Gao, L. Geng, G. Kvalheim, G. Gaudernack +1 more
2009Ultrastructural Pathology47 citations
Semantic Scholar
Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
P. Brunsvig, T. Guren, M. Nyakas, Claudius H. Steinfeldt-Reisse +6 more
2020Frontiers in Immunology44 citations Open access
Semantic Scholar
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
N. Mensali, H. Köksal, Sandy Joaquina, P. Wernhoff +23 more
2023Nature Communications43 citations Open access
Semantic Scholar
Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
E. Ellingsen, E. Aamdal, T. Guren, W. Lilleby +7 more
2022Journal for ImmunoTherapy of Cancer37 citations Open access
Semantic Scholar
Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial
E. Aamdal, E. Inderberg, E. Ellingsen, W. Rasch +9 more
2021Frontiers in Immunology37 citations Open access
Semantic Scholar
Polyelectrolyte multilayer capsules with quantum dots for biomedical applications.
M. Adamczak, Hanna Julie Hoel, G. Gaudernack, J. Barbasz +2 more
2012Colloids and Surfaces B: Biointerfaces35 citations
Semantic Scholar
Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential
E. Ellingsen, S. Mangsbo, E. Hovig, G. Gaudernack
2021Frontiers in Immunology31 citations Open access
Semantic Scholar
Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity
N. Mensali, Amalie C. Grenov, N. Pati, Pierre Dillard +6 more
2019Oncoimmunology30 citations Open access
Semantic Scholar
Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia
S. Jarnjak-Jankovic, R. Pettersen, S. Saebøe-Larssen, F. Wesenberg +1 more
2005BMC Cancer30 citations Open access
Semantic Scholar
Resolving the evolutionary paradox of genetic instability: a cost–benefit analysis of DNA repair in changing environments
J. Breivik, G. Gaudernack
2004FEBS Letters30 citations
Semantic Scholar
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
Pierre Dillard, H. Köksal, S. M. Maggadóttir, Anna Winge-Main +9 more
2020Molecular Therapy29 citations Open access
Semantic Scholar
Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma
S. Jarnjak-Jankovic, R. Pettersen, S. Saebøe-Larssen, F. Wesenberg +2 more
2005Cancer Gene Therapy24 citations Open access
Semantic Scholar
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
E. Ellingsen, G. Bounova, I. Kerzeli, Irantzu Anzar +10 more
2022Journal of Translational Medicine21 citations Open access
Semantic Scholar
Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab
O. Yri, P. O. Ekstrøm, V. Hilden, G. Gaudernack +3 more
2013Leukemia and Lymphoma20 citations
Semantic Scholar
T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy
J. Kyte, G. Gaudernack, A. Faane, K. Lislerud +6 more
2016Oncoimmunology18 citations Open access
Semantic Scholar
Dendritic Cells Engineered to Express Defined Allo‐HLA Peptide Complexes Induce Antigen‐specific Cytotoxic T Cells Efficiently Killing Tumour Cells
Erlend Strønen, I. Abrahamsen, G. Gaudernack, S. Wälchli +5 more
2009Scandinavian Journal of Immunology18 citations Open access
Semantic Scholar
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
Pierre Dillard, N. Casey, S. Pollmann, Patrik Vernhoff +4 more
2021Oncoimmunology17 citations Open access
Semantic Scholar
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
N. Mensali, M. R. Myhre, Pierre Dillard, S. Pollmann +4 more
2019Cancer Immunology and Immunotherapy17 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Kvalheim×21
Invite
G. Kvalheim — researcher profile on SciRah
E. Inderberg×15
Invite
E. Inderberg — researcher profile on SciRah
S. Aamdal×14
Invite
S. Aamdal — researcher profile on SciRah
J. Kyte×12
Invite
J. Kyte — researcher profile on SciRah

×11

Invite

S. Wälchli — researcher profile on SciRah

Invite

P. Brunsvig — researcher profile on SciRah

Invite

M. R. Myhre — researcher profile on SciRah

S. Saebøe-Larssen×5

Invite

S. Saebøe-Larssen — researcher profile on SciRah

A. Rasmussen×5

Invite

A. Rasmussen — researcher profile on SciRah

Sissel Trachsel×5

Invite

Sissel Trachsel — researcher profile on SciRah

Invite

N. Mensali — researcher profile on SciRah

Pierre Dillard×5

Invite

Pierre Dillard — researcher profile on SciRah